Patents by Inventor Dagmar Alber

Dagmar Alber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-BACTERIAL COMPOUNDS BASED ON AMINO-GOLD PHOSPHINE COMPLEXES
    Publication number: 20180369258
    Abstract: A compound of formula (I) for use in the prevention or treatment of a bacterial infection wherein: PX is selected from the group consisting of (P1), (P2) and (P3).
    Type: Application
    Filed: December 2, 2016
    Publication date: December 27, 2018
    Applicant: Auspherix Limited
    Inventors: Ian HOLMES, Alan NAYLOR, Dagmar ALBER, Jonathan Raymond POWELL, Meriel Ruth MAJOR, Gabriel NEGOITA-GIRAS, Daniel Rees ALLEN, Lucie Juliette GUETZOYAN, Nigel Paul KING, Nicholas Andrew CHAPMAN
  • ANTI-BACTERIAL COMPOUNDS
    Publication number: 20180360856
    Abstract: A compound of Formula (II): for use in the prevention or treatment of a bacterial infection.
    Type: Application
    Filed: December 2, 2016
    Publication date: December 20, 2018
    Applicant: Auspherix Limited
    Inventors: Ian HOLMES, Alan NAYLOR, Dagmar ALBER, Jonathan Raymond POWELL, Meriel Ruth MAJOR, Gabriel NEGOITA-GIRAS, Daniel Rees ALLEN, Lucie Juliette GUETZOYAN, Nigel Paul KING
  • Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein
    Patent number: 8853204
    Abstract: A pharmaceutical composition which comprises a pharmaceutically acceptable carrier or diluent and: (a) an inhibitor of the RSV fusion protein; and (b) a benzodiazepine derivative capable of inhibiting RSV replication is found to be highly active against RSV.
    Type: Grant
    Filed: March 18, 2005
    Date of Patent: October 7, 2014
    Assignee: Arrow Therapeutics Limited
    Inventors: Kenneth Powell, Richard Kelsey, Malcolm Carter, Dagmar Alber, Lara Wilson, Elisa Henderson, Phil Chambers, Debra Taylor, Stan Tyms, Verity Dowdell
  • Benzodiazepines for Treating or Preventing Rsv Infection
    Publication number: 20080139536
    Abstract: Use of a compound which is (a) a benzodiazepine derivative of the formula (I) or an N-oxide thereof or (b) a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in treating or preventing an RSV infection wherein: —R1 represents C1-6 alkyl, aryl or heteroaryl; —R2 represents hydrogen or C1-6 alkyl; each R3 is the same or different and represents halogen, hydroxy, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 haloalkyl, C1-6 haloalkoxy, amino, mono(C1-6 alkyl)amino, di(C1-6alkyl)amino, vitro, cyano, —CO2R?, —CONR?R?, —NH—CO—R?, —S(O)R?, —S(O)2R?, —NH—S(O)2R?, —S(O)NR?R? or —S(O)2NR?R?, wherein each R? and R? is the same or different and represents hydrogen or C1-6 alkyl; n is from O to 3; R4 represents hydrogen or C1-6 alkyl; X represents —CO—, —CO—NR?—, —S(O)— or —S(O)2—, wherein R? is hydrogen or a C1-C6 alkyl group; and R5 represents a heteroaryl or heterocyclyl group which is substituted by a C1C6 hydroxyalkyl group or a —(C1-C4 alkyl)-X1—(C1-C4 alkyl)-X2—(C1-C4 alkyl} group
    Type: Application
    Filed: March 18, 2005
    Publication date: June 12, 2008
    Applicant: Novartis Pharmaceuticals Corporation
    Inventors: Verity Dowdell, Richard Kelsey, Malcolm Carter, Dagmar Alber, Elisa Henderson
  • Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
    Publication number: 20070185096
    Abstract: A pharmaceutical composition which comprises a pharmaceutically acceptable carrier or diluent and: (a) an inhibitor of the RSV fusion protein; and (b) a benzodiazepine derivative capable of inhibiting RSV replication is found to be highly active against RSV.
    Type: Application
    Filed: March 18, 2005
    Publication date: August 9, 2007
    Applicant: Novartis Pharmaceuticals Corporation
    Inventors: Kenneth Powell, Richard Kelsey, Malcolm Carter, Verity Dowdell, Dagmar Alber, Elisa Henderson
  • Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
    Publication number: 20070142403
    Abstract: A pharmaceutical composition which comprises a pharmaceutically acceptable carrier or diluent and: (a) an inhibitor of the RSV fusion protein; and (b) a benzodiazepine derivative capable of inhibiting RSV replication is found to be highly active against RSV.
    Type: Application
    Filed: March 18, 2005
    Publication date: June 21, 2007
    Applicant: Novartis Pharmaceuticala Corporation
    Inventors: Kenneth Powell, Richard Kelsey, Malcolm Carter, Dagmar Alber, Lara Wilson, Elisa Henderson, Phil Chambers, Debra Taylor, Stan Tyms, Verity Dowdell